Androgen News and Research

RSS

New study unlocks hope for immunotherapy in metastatic prostate cancer

Immunotherapy has been disappointing as a prostate cancer treatment, but a new Columbia study suggests that the powerful treatments have potential when the disease starts to spread.

12 Dec 2023

Birth control pills may alter stress response, increase inflammation risk, study suggests

A new UCLA Health study is shedding light on how using hormonal contraceptive pills may affect women's responses to stress and their risk for inflammation-related illnesses.

7 Dec 2023

Are there racial and ethnic disparities in the use of novel hormonal therapy agents in men with advanced prostate cancer?

Researchers assessed ethnic and racial differences in novel hormonal therapy (NHT) use among advanced prostate cancer (PCa) patients.

6 Dec 2023

Study exploits biomolecular condensates to inhibit androgen receptor in prostate cancer

Transcription factors play essential roles in turning the genetic information encoded in genes into proteins in all cells and organisms.

5 Dec 2023

UCLA studies unravel metabolic pathways in prostate cancer treatment

Two new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way prostate tumors survive and grow -; advancements that can help explain why some prostate cancers become resistant to hormone therapy, the most commonly used treatment for men with advanced stages of the disease.

4 Dec 2023

Study finds racial disparity in the utilization of crucial prostate cancer therapy

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups – including white or Latino men – despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.

1 Dec 2023

Obesity linked to prostate cancer risk: New study uncovers inherited dangers from fathers

Obesity contributes to prostate cancer risk and can be inherited from obese fathers, as shown in a review of over 280 studies examining obesity's impact on carcinogenesis and heritability.

23 Nov 2023

Dietary saturated fats may influence male hormone levels, new study suggests

Study finds no independent link between dietary fats and androgen levels in middle-aged men; however, replacing protein calories with saturated fatty acids may raise serological androgen levels, suggesting diet's potential impact on male hormonal health.

23 Nov 2023

Exploring the impact of soy isoflavones in prostate cancer therapy

The cellular mechanisms of soy isoflavones, genistein, daidzein, and equol.

23 Nov 2023

Study links lower testosterone levels with increased arthritis risk

The relationship between serological testosterone levels and arthritis among United States (US) adults.

9 Nov 2023

UTHSC's drug candidate for advanced prostate cancer goes to first clinical trial

A drug candidate developed by researchers at the University of Tennessee Health Science Center for advanced metastatic castration-resistant prostate cancer is now in its first clinical trial.

6 Nov 2023

Docetaxel improves survival in men with high-grade prostate cancer and low PSA

Men with high-grade prostate cancer and low prostate-specific antigen (PSA) levels have a poor prognosis.

1 Nov 2023

Ketogenic diet boosts IVF success for women with PCOS, study reveals

A recent study in the journal "Nutrients" investigated the effects of dietary interventions, including the Mediterranean diet (MD) and a very low-calorie ketogenic diet (VLCKD), on overweight or obese women with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilization (IVF).

24 Oct 2023

Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Researchers discuss the results of a randomized controlled trial to explore the impact of diet on breast cancer recurrence.

20 Oct 2023

Scientists identify two promising new treatment options for men with recurrent prostate cancer

Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer-; both of which helped patients live longer without their disease progressing than the current standard treatment.

18 Oct 2023

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer.

11 Oct 2023

Altering certain molecular interactions could yield new strategies for treating prostate cancer

Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered that altering certain molecular interactions could yield new strategies for treating prostate cancer and related diseases.

6 Oct 2023

Androgen News and Research

New study unlocks hope for immunotherapy in metastatic prostate cancer

Birth control pills may alter stress response, increase inflammation risk, study suggests

Are there racial and ethnic disparities in the use of novel hormonal therapy agents in men with advanced prostate cancer?

Study exploits biomolecular condensates to inhibit androgen receptor in prostate cancer

UCLA studies unravel metabolic pathways in prostate cancer treatment

Study finds racial disparity in the utilization of crucial prostate cancer therapy

Obesity linked to prostate cancer risk: New study uncovers inherited dangers from fathers

Dietary saturated fats may influence male hormone levels, new study suggests

Exploring the impact of soy isoflavones in prostate cancer therapy

Study links lower testosterone levels with increased arthritis risk

UTHSC's drug candidate for advanced prostate cancer goes to first clinical trial

Docetaxel improves survival in men with high-grade prostate cancer and low PSA

Ketogenic diet boosts IVF success for women with PCOS, study reveals

Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Scientists identify two promising new treatment options for men with recurrent prostate cancer

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

Altering certain molecular interactions could yield new strategies for treating prostate cancer

Can human chorionic gonadotropin supplements enhance penile growth?

New drugs have increased survival rates for men with metastatic prostate cancer

Key player in ovarian cancer may have implications for PCOS

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News